{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:09:52Z","timestamp":1789582192446,"version":"build-2803163510"},"reference-count":195,"publisher":"Portland Press Ltd.","issue":"1","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bile acids synthesized within the hepatocytes are transformed by gut microorganisms and reabsorbed into the portal circulation. During their enterohepatic cycling, bile acids act as signaling molecules by interacting with receptors to regulate pathways involved in many physiological processes. The bile acid pool, composed of a variety of bile acid species, has been shown to be altered in diseases, hence contributing to disease pathogenesis. Thus, understanding the changes in bile acid pool size and composition in pathological processes will help to elaborate effective pharmacological treatments.<\/jats:p>\n                  <jats:p>Five crucial steps along the enterohepatic cycle shape the bile acid pool size and composition, offering five possible targets for therapeutic intervention. In this review, we provide an insight on the strategies to modulate the bile acid pool, and then we discuss the potential benefits in non-alcoholic fatty liver disease.<\/jats:p>","DOI":"10.1042\/cs20220697","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:01:23Z","timestamp":1672887683000},"page":"65-85","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease"],"prefix":"10.1042","volume":"137","author":[{"given":"Justine","family":"Gillard","sequence":"first","affiliation":[{"name":"Laboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7934-6693","authenticated-orcid":false,"given":"Isabelle A.","family":"Leclercq","sequence":"additional","affiliation":[{"name":"Laboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"2023010508004414800_B1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"key":"2023010508004414800_B2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.livres.2019.05.001","article-title":"The acidic pathway of bile acid synthesis: Not just an alternative pathway","volume":"3","author":"Pandak","year":"2019","journal-title":"Liver Res."},{"key":"2023010508004414800_B3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/S0022-2275(20)33481-7","article-title":"27-Hydroxycholesterol\u202f: production rates in normal human subjects","volume":"40","author":"Duane","year":"1999","journal-title":"J. Lipid Res. N.d."},{"key":"2023010508004414800_B4","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023010508004414800_B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"2023010508004414800_B6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"BBA - Mol. Basis Dis."},{"key":"2023010508004414800_B8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1194\/jlr.RA119000243","article-title":"A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice","volume":"61","author":"de Boer","year":"2020","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B9","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1194\/jlr.RA119000307","article-title":"Of mice and men\u202f: Murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism","volume":"61","author":"Straniero","year":"2020","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.017400","article-title":"How informative is the mouse for human gut microbiota research?","volume":"8","author":"Nguyen","year":"2015","journal-title":"DMM Dis. Model Mech."},{"key":"2023010508004414800_B12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1194\/jlr.C120000621","article-title":"Is CYP2C70 the key to new mouse models to understand bile acids in humans?","volume":"61","author":"Guo","year":"2020","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling \u2014 mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"2023010508004414800_B15","doi-asserted-by":"crossref","first-page":"100214","DOI":"10.1016\/j.jhepr.2020.100214","article-title":"TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload","volume":"3","author":"Bidault-Jourdainne","year":"2020","journal-title":"JHEP Rep."},{"key":"2023010508004414800_B16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s42255-022-00559-z","article-title":"Metabolic messengers: bile acids","volume":"4","author":"Perino","year":"2022","journal-title":"Nat. Metab."},{"key":"2023010508004414800_B17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol. Rev."},{"key":"2023010508004414800_B18","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, Type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B19","doi-asserted-by":"publisher","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"2023010508004414800_B20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jhep.2021.03.020","article-title":"FXR agonists for NASH: How are they different and what difference do they make?","volume":"75","author":"Kremoser","year":"2021","journal-title":"J. Hepatol."},{"key":"2023010508004414800_B21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/apt.15035","article-title":"Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD","volume":"49","author":"Caussy","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2023010508004414800_B22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"2023010508004414800_B23","doi-asserted-by":"publisher","first-page":"41334","DOI":"10.1074\/jbc.M112.421834","article-title":"Nuclear receptors HNF4\u03b1 and LRH-1 cooperate in regulating Cyp7a1 in vivo","volume":"287","author":"Kir","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2023010508004414800_B24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev."},{"key":"2023010508004414800_B25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"2023010508004414800_B26","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev."},{"key":"2023010508004414800_B27","doi-asserted-by":"publisher","first-page":"27277","DOI":"10.1074\/jbc.M704244200","article-title":"Liver-specific activities of FGF19 require Klotho beta * \u25a1","volume":"282","author":"Lin","year":"2007","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B28","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1194\/jlr.M064709","article-title":"Cholesterol 7\u03b1-hydroxylase-deficient mice are protected from high-fat\/high-cholesterol diet-induced metabolic disorders","volume":"57","author":"Ferrell","year":"2016","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B29","doi-asserted-by":"publisher","first-page":"hep","DOI":"10.1002\/hep.30612","article-title":"Bile acid homeostasis in a cholesterol 7\u03b1-hydroxylase and sterol 27-hydroxylase double knockout mouse model","volume":"70","author":"Rizzolo","year":"2019","journal-title":"Hepatology"},{"key":"2023010508004414800_B30","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"2023010508004414800_B31","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.1074\/jbc.M117.784322","article-title":"Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism","volume":"292","author":"Pathak","year":"2017","journal-title":"J. Biol. Chem."},{"key":"2023010508004414800_B32","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2018.06.038","article-title":"An FXR agonist reduces bile acid synthesis independently of increases in FGF19 in healthy volunteers","volume":"155","author":"Al-Khaifi","year":"2018","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B33","doi-asserted-by":"publisher","first-page":"574.e1","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid x receptor agonist Obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/apt.12999","article-title":"The response of patients with bile acid diarrhoea to the farnesoid x receptor agonist obeticholic acid","volume":"41","author":"Walters","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2023010508004414800_B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Harrison","year":"2021","journal-title":"J. Hepatol."},{"key":"2023010508004414800_B36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.31205","article-title":"Cilofexor, a nonsteroidal FXR agonist, in non-cirrhotic patients with nonalcoholic steatohepatitis: a phase 2 randomized controlled trial","volume":"72","author":"Patel","year":"2020","journal-title":"Hepatology"},{"key":"2023010508004414800_B37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"key":"2023010508004414800_B38","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"2023010508004414800_B39","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"2023010508004414800_B40","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.3390\/nu14132707","article-title":"Enterohepatic Takeda G-protein coupled receptor 5 agonism in metabolic dysfunction-associated fatty liver disease and related glucose dysmetabolism","volume":"14","author":"Gillard","year":"2022","journal-title":"Nutrients"},{"key":"2023010508004414800_B41","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/hep4.1108","article-title":"Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice","volume":"1","author":"Zhou","year":"2020","journal-title":"Hepatol. Commun."},{"key":"2023010508004414800_B42","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1158\/0008-5472.CAN-14-0208","article-title":"Separating tumorigenicity from bile acid regulatory activity for endocrine hormone FGF19","volume":"74","author":"Zhou","year":"2014","journal-title":"Cancer Res."},{"key":"2023010508004414800_B43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jhep.2018.11.032","article-title":"Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis lipid changes in patients with non-alcoholic steatohepatitis","volume":"70","author":"Rinella","year":"2019","journal-title":"J. Hepatol."},{"key":"2023010508004414800_B44","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.jhepr.2021.100255","article-title":"Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases","volume":"3","author":"Sanyal","year":"2021","journal-title":"JHEP Rep."},{"key":"2023010508004414800_B45","doi-asserted-by":"publisher","first-page":"219.e1","DOI":"10.1053\/j.gastro.2020.08.004","article-title":"Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis","volume":"160","author":"Harrison","year":"2021","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B46","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jhep.2021.01.028","article-title":"STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway","volume":"74","author":"Conde de la Rosa","year":"2021","journal-title":"J. Hepatol."},{"key":"2023010508004414800_B47","doi-asserted-by":"publisher","first-page":"21805","DOI":"10.1074\/jbc.C000275200","article-title":"Bile acid induction of cytokine expression by macrophages correlates with. repression of hepatic cholesterol 7\u03b1-hydroxylase","volume":"275","author":"Miyake","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2023010508004414800_B48","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/hep.23089","article-title":"Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"2023010508004414800_B49","doi-asserted-by":"publisher","first-page":"12598","DOI":"10.1021\/bi050943e","article-title":"Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice","volume":"44","author":"Lam","year":"2005","journal-title":"Biochemistry"},{"key":"2023010508004414800_B50","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molmed.2007.06.001","article-title":"Targeting farnesoid X receptor for liver and metabolic disorders","volume":"13","author":"Fiorucci","year":"2007","journal-title":"Trends Mol. Med."},{"key":"2023010508004414800_B51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B52","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1124\/dmd.115.065276","article-title":"Importance of large intestine in regulating bile acids and glucagon-like peptide-1 in germ-free mice","volume":"43","author":"Selwyn","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"2023010508004414800_B53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"2023010508004414800_B54","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1073\/pnas.1006734107","article-title":"Systemic gut microbial modulation of bile acid metabolism in host tissue compartments","volume":"108","author":"Swann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023010508004414800_B55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","article-title":"Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome","volume":"7","author":"Song","year":"2019","journal-title":"Microbiome"},{"key":"2023010508004414800_B56","doi-asserted-by":"publisher","first-page":"e2017709118","DOI":"10.1073\/pnas.2017709118","article-title":"Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization","volume":"118","author":"Foley","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2023010508004414800_B57","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"2023010508004414800_B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1854008","article-title":"The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice","volume":"13","author":"Streidl","year":"2021","journal-title":"Gut Microbes"},{"key":"2023010508004414800_B59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"2023010508004414800_B60","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00805-21","article-title":"Dominant bacterial phyla from the human gut show widespread ability to transform and conjugate bile acids","volume":"6","author":"Lucas","year":"2021","journal-title":"MSystems"},{"key":"2023010508004414800_B61","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nchembio.1864","article-title":"A biosynthetic pathway for a prominent class of microbiota-derived bile acids","volume":"11","author":"Devlin","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"2023010508004414800_B62","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04480-z","volume-title":"Human gut bacteria produce \u03a4\u039717-modulating bile acid metabolites","author":"Paik","year":"2022"},{"key":"2023010508004414800_B63","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","article-title":"Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians","volume":"599","author":"Sato","year":"2021","journal-title":"Nature"},{"key":"2023010508004414800_B64","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"2023010508004414800_B65","doi-asserted-by":"publisher","first-page":"1366.e9","DOI":"10.1016\/j.chom.2021.07.013","article-title":"Article A bacterial bile acid metabolite modulates T reg activity through the nuclear hormone receptor NR4A1 A bacterial bile acid metabolite modulates T reg activity through the nuclear hormone receptor NR4A1","volume":"29","author":"Li","year":"2021","journal-title":"Cell Host Microbe"},{"key":"2023010508004414800_B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"2023010508004414800_B67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"key":"2023010508004414800_B68","doi-asserted-by":"publisher","first-page":"110310","DOI":"10.1016\/j.biopha.2020.110310","article-title":"The influence of probiotics on bile acids in diseases and aging","volume":"128","author":"Sivamaruthi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"2023010508004414800_B69","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1128\/AEM.72.3.1729-1738.2006","article-title":"Bile salt hydrolase activity in probiotics","volume":"72","author":"Begley","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"2023010508004414800_B70","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut","volume":"111","author":"Joyce","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023010508004414800_B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2022.06.050","article-title":"Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes","volume":"185","author":"Russell","year":"2022","journal-title":"Cell"},{"key":"2023010508004414800_B72","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.12998\/wjcc.v8.i8.1361","article-title":"Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases","volume":"8","author":"Cheng","year":"2020","journal-title":"World J. Clin. Cases"},{"key":"2023010508004414800_B73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.celrep.2014.02.032","article-title":"Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice","volume":"7","author":"Degirolamo","year":"2014","journal-title":"Cell Rep."},{"key":"2023010508004414800_B74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/19490976.2015.1005474","article-title":"Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242","volume":"6","author":"Martoni","year":"2015","journal-title":"Gut Microbes"},{"key":"2023010508004414800_B75","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1017\/S0007114511004703","article-title":"Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults","volume":"107","author":"Jones","year":"2012","journal-title":"Br. J. Nutr."},{"key":"2023010508004414800_B76","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ejcn.2012.126","article-title":"Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized controlled trial","volume":"66","author":"Jones","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"key":"2023010508004414800_B77","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3920\/BM2018.0151","article-title":"Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study","volume":"10","author":"Culpepper","year":"2019","journal-title":"Benef. Microbes"},{"key":"2023010508004414800_B78","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1128\/aem.63.3.1185-1188.1997","article-title":"Assessment of fecal bacteria with bile acid 7-dehydroxylating activity for the presence of bai-like genes","volume":"63","author":"Doerner","year":"1997","journal-title":"Appl. Environ. Microbiol."},{"key":"2023010508004414800_B79","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","article-title":"Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile","volume":"517","author":"Buffie","year":"2015","journal-title":"Nature"},{"key":"2023010508004414800_B80","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"2023010508004414800_B81","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1172\/JCI133605","article-title":"Gut microbiome communication with bone marrow regulates susceptibility to amebiasis","volume":"140","author":"Burgess","year":"2020","journal-title":"J. Clin. Invest."},{"key":"2023010508004414800_B82","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/19490976.2018.1549420","article-title":"In vitro and in vivo characterization of Clostridium scindens bile acid transformations","volume":"10","author":"Marion","year":"2019","journal-title":"Gut Microbes"},{"key":"2023010508004414800_B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23460-x","article-title":"Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis","volume":"12","author":"van der Lelie","year":"2021","journal-title":"Nat. Commun."},{"key":"2023010508004414800_B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.02871","article-title":"Consortium of probiotics attenuates colonization of Clostridioides difficile","volume":"10","author":"Li","year":"2019","journal-title":"Front Microbiol."},{"key":"2023010508004414800_B85","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12876-018-0860-5","article-title":"Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection","volume":"18","author":"Brown","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"2023010508004414800_B86","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.anaerobe.2018.04.001","article-title":"Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection","volume":"53","author":"Seekatz","year":"2018","journal-title":"Anaerobe"},{"key":"2023010508004414800_B87","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1136\/gutjnl-2018-317842","article-title":"Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection","volume":"68","author":"Mullish","year":"2019","journal-title":"Gut"},{"key":"2023010508004414800_B88","first-page":"G310","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"2023010508004414800_B89","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/19490976.2017.1299310","article-title":"Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota","volume":"8","author":"Staley","year":"2017","journal-title":"Gut Microbes"},{"key":"2023010508004414800_B90","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejphar.2012.09.048","article-title":"Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling","volume":"697","author":"Kuribayashi","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"2023010508004414800_B91","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1038\/s41467-018-05336-9","article-title":"Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism","volume":"9","author":"Zarrinpar","year":"2018","journal-title":"Nat. Commun."},{"key":"2023010508004414800_B92","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0016-5085(96)70024-0","article-title":"7\u03b1-Dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones","volume":"111","author":"Berr","year":"1996","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.00336","article-title":"Saccharomyces boulardii CNCM I-745 modulates the fecal bile acids metabolism during antimicrobial therapy in healthy volunteers","volume":"10","author":"Kelly","year":"2019","journal-title":"Front. Microbiol."},{"key":"2023010508004414800_B94","doi-asserted-by":"publisher","first-page":"108142","DOI":"10.1016\/j.celrep.2020.108142","article-title":"Article infection with bacteroides phage BV01 Alters the host transcriptome and bile acid metabolism in a common human gut microbe ll ll infection with bacteroides phage BV01 alters the host transcriptome and bile acid metabolism in a common human gut mic","volume":"32","author":"Campbell","year":"2020","journal-title":"Cell Rep."},{"key":"2023010508004414800_B95","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1021\/acschembio.1c00192","article-title":"A gut-restricted lithocholic acid analog as an inhibitor of gut bacterial bile salt hydrolases","volume":"16","author":"Adhikari","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"2023010508004414800_B96","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41589-020-0467-3","article-title":"Development of a covalent inhibitor of gut bacterial bile salt hydrolases","volume":"16","author":"Adhikari","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"2023010508004414800_B97","first-page":"1","article-title":"Circulating bile acids as a link between the gut microbiota and cardiovascular health: Impact of Prebiotics, probiotics and polyphenol-rich foods","volume":"35","author":"Pushpass","year":"2021","journal-title":"Nutr. Res. Rev."},{"key":"2023010508004414800_B98","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1002\/ptr.7517","article-title":"Gut microbiota, bile acids, and nature compounds","volume":"36","author":"Cheng","year":"2022","journal-title":"Phyther. Res."},{"key":"2023010508004414800_B99","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2017.05.055","article-title":"Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity","volume":"153","author":"Nicolucci","year":"2017","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gutjnl-2021-326541","article-title":"6\u03b1-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice","author":"Makki","year":"2022","journal-title":"Gut"},{"key":"2023010508004414800_B101","doi-asserted-by":"publisher","first-page":"100182","DOI":"10.1016\/j.phanu.2020.100182","article-title":"PharmaNutrition prebiotics may alter bile salt hydrolase activity\u202f: possible implications for cholesterol metabolism","volume":"12","author":"Adebola","year":"2020","journal-title":"Pharma. Nutrition"},{"key":"2023010508004414800_B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-020-02020-1","article-title":"Berberine alters gut microbial function through modulation of bile acids","volume":"21","author":"Wolf","year":"2021","journal-title":"BMC Microbiol."},{"key":"2023010508004414800_B103","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/mol.116.106617","article-title":"Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway","volume":"91","author":"Sun","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"2023010508004414800_B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-016-1367-7","article-title":"Dose-response effect of berberine on bile acid profile and gut microbiota in mice","volume":"16","author":"Guo","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"2023010508004414800_B105","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cells10020210","article-title":"Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"2023010508004414800_B106","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/dmd.118.083691","article-title":"Berberine directly affects the gut microbiota to promote intestinal farnesoid X receptor activation","volume":"47","author":"Tian","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"2023010508004414800_B107","doi-asserted-by":"publisher","first-page":"e0202083","DOI":"10.1371\/journal.pone.0202083","article-title":"Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids","volume":"13","author":"Watanabe","year":"2018","journal-title":"PLoS ONE"},{"key":"2023010508004414800_B108","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.isci.2019.08.020","article-title":"Blueberry extract improves obesity through regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5","volume":"19","author":"Guo","year":"2019","journal-title":"IScience"},{"key":"2023010508004414800_B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"key":"2023010508004414800_B110","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1152\/ajpendo.00323.2011","article-title":"Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes","volume":"302","author":"Chen","year":"2012","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"key":"2023010508004414800_B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0037787","article-title":"Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice","volume":"7","author":"Lund\u00e5sen","year":"2012","journal-title":"PLoS ONE"},{"key":"2023010508004414800_B112","doi-asserted-by":"publisher","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"2023010508004414800_B113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12876-017-0736-0","article-title":"Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial","volume":"18","author":"Tiessen","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"2023010508004414800_B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-018-0200-y","article-title":"A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: Implications for treatment of non-alcoholic steatohepatitis","volume":"19","author":"Palmer","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"2023010508004414800_B115","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/dom.12656","article-title":"Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin","volume":"18","author":"Nunez","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"2023010508004414800_B116","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apt.13457","article-title":"The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation","volume":"43","author":"Graffner","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2023010508004414800_B117","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jcmgh.2017.11.011","article-title":"Intestinal farnesoid X receptor activation by pharmacologic inhibition of the organic solute transporter \u03b1-\u03b2","volume":"5","author":"van de Wiel","year":"2018","journal-title":"Cmgh"},{"key":"2023010508004414800_B118","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11892-009-0087-5","article-title":"Bile acid sequestrants for lipid and glucose control","volume":"10","author":"Staels","year":"2010","journal-title":"Curr. Diab. Rep."},{"key":"2023010508004414800_B119","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1194\/jlr.M007641","article-title":"Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice","volume":"51","author":"Zhang","year":"2010","journal-title":"J. Lipid Res."},{"key":"2023010508004414800_B120","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12072-022-10296-w","article-title":"Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice","volume":"16","author":"Hartmann","year":"2022","journal-title":"Hepatol. Int."},{"key":"2023010508004414800_B121","doi-asserted-by":"publisher","first-page":"e38286","DOI":"10.1371\/journal.pone.0038286","article-title":"Bile acid binding resin improves metabolic control through the induction of energy expenditure","volume":"7","author":"Watanabe","year":"2012","journal-title":"PLoS ONE"},{"key":"2023010508004414800_B122","first-page":"0","article-title":"Targeting the four pillars of enterohepatic bile salt cycling; lessons from genetics and pharmacology","volume":"73","author":"Kunst","year":"2020","journal-title":"Hepatology"},{"key":"2023010508004414800_B123","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jhep.2016.04.013","article-title":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","volume":"65","author":"Blank","year":"2016","journal-title":"J. Hepatol."},{"key":"2023010508004414800_B124","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/cpt.744","article-title":"The NTCP-inhibitor Myrcludex B: effects on bile acid disposition and tenofovir pharmacokinetics","volume":"103","author":"Blank","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023010508004414800_B125","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J. Hepatol."},{"key":"2023010508004414800_B126","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na + -taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"2023010508004414800_B127","doi-asserted-by":"publisher","first-page":"11853","DOI":"10.1074\/jbc.RA118.007179","article-title":"Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency","volume":"294","author":"Mao","year":"2019","journal-title":"J. Biol. Chem."},{"key":"2023010508004414800_B128","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/hep.29251","article-title":"Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice LIVER BIOLOGY\/PATHOBIOLOGY A HE S","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatology"},{"key":"2023010508004414800_B129","volume-title":"Mechanistical insights to the inhibition of NTCP by Myrcludex B","author":"Donkers","year":"2019"},{"key":"2023010508004414800_B130","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jcmgh.2020.04.009","article-title":"Inhibition of hepatic bile acid uptake by myrcludex B promotes glucagon-like peptide-1 release and reduces obesity","volume":"10","author":"Donkers","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2023010508004414800_B131","doi-asserted-by":"publisher","first-page":"100387","DOI":"10.1016\/j.jhepr.2021.100387","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep."},{"key":"2023010508004414800_B132","doi-asserted-by":"publisher","first-page":"11761","DOI":"10.1074\/jbc.M112.446575","article-title":"El, et al. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease","volume":"288","author":"McMahan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2023010508004414800_B133","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3748\/wjg.v24.i2.195","article-title":"INT-767 improves histopathological features in a dietinduced ob\/ob mouse model of biopsy-confirmed nonalcoholic steatohepatitis","volume":"24","author":"Roth","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"2023010508004414800_B134","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/hep4.1256","article-title":"FXR and TGR5 agonists ameliorate liver injury, steatosis, and inflammation after binge or prolonged alcohol feeding in mice","volume":"2","author":"Iracheta-Vellve","year":"2018","journal-title":"Hepatol. Commun."},{"key":"2023010508004414800_B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42801","article-title":"BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis","volume":"7","author":"Carino","year":"2017","journal-title":"Sci. Rep."},{"key":"2023010508004414800_B136","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcmgh.2020.02.005","article-title":"A physiology-based model of bile acid distribution and metabolism under healthy and pathologic conditions in human beings","volume":"10","author":"Voronova","year":"2020","journal-title":"Cmgh"},{"key":"2023010508004414800_B137","doi-asserted-by":"publisher","first-page":"1802.e5","DOI":"10.1016\/j.chom.2021.11.003","article-title":"Characterization of gut microbial structural variations as determinants of human bile acid metabolism","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"2023010508004414800_B138","first-page":"435","article-title":"Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice","volume":"68","author":"Anh\u00ea","year":"2018","journal-title":"Gut"},{"key":"2023010508004414800_B139","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s41467-022-29589-7","article-title":"Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"2023010508004414800_B140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-021-00595-8","article-title":"Metabolomic signatures for liver tissue and cecum contents in high-fat diet-induced obese mice based on UHPLC-Q-TOF\/MS","volume":"18","author":"Cai","year":"2021","journal-title":"Nutr. Metab."},{"key":"2023010508004414800_B141","doi-asserted-by":"publisher","first-page":"1098.e18","DOI":"10.1016\/j.cell.2019.01.036","article-title":"FXR regulates intestinal cancer stem cell proliferation","volume":"176","author":"Fu","year":"2019","journal-title":"Cell"},{"key":"2023010508004414800_B142","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1096\/fj.201801373RR","article-title":"Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis","volume":"33","author":"Carino","year":"2019","journal-title":"FASEB J."},{"key":"2023010508004414800_B143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0247303","article-title":"Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats","volume":"16","author":"Nakade","year":"2021","journal-title":"PLoS ONE"},{"key":"2023010508004414800_B144","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"2023010508004414800_B145","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/nu12010047","article-title":"Associations between dietary patterns and bile acids\u2014results from a cross-sectional study in vegans and omnivores","volume":"12","author":"Trefflich","year":"2019","journal-title":"Nutrients"},{"key":"2023010508004414800_B146","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3945\/ajcn.115.109116","article-title":"Diets with high-fat cheese, high-fat meat, or carbohydrate on cardiovascular risk markers in overweight postmenopausal women: a randomized crossover trial","volume":"102","author":"Thorning","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"2023010508004414800_B147","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3945\/ajcn.112.056689","article-title":"Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans","volume":"98","author":"Ou","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"2023010508004414800_B148","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1038\/ncomms7342","article-title":"Fat, fibre and cancer risk in African Americans and rural Africans","volume":"6","author":"O'Keefe","year":"2015","journal-title":"Nat. Commun."},{"key":"2023010508004414800_B149","doi-asserted-by":"publisher","first-page":"e0117421","DOI":"10.1128\/msystems.01174-21","article-title":"Bile acids, gut microbes, and the neighborhood food environment-a potential driver of colorectal cancer health disparities","volume":"7","author":"Wolf","year":"2022","journal-title":"MSystems"},{"key":"2023010508004414800_B150","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.taap.2013.10.020","article-title":"Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice","volume":"273","author":"Fu","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2023010508004414800_B151","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41586-021-03663-4","article-title":"Caloric restriction disrupts the microbiota and colonization resistance","volume":"595","author":"von Schwartzenberg","year":"2021","journal-title":"Nature"},{"key":"2023010508004414800_B152","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/liv.15098","article-title":"Changes in bile acid subtypes and long-term successful weight-loss in response to weight-loss diets: The POUNDS lost trial","volume":"42","author":"Heianza","year":"2022","journal-title":"Liver Int."},{"key":"2023010508004414800_B153","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/joim.12599","article-title":"Acute caloric restriction counteracts hepatic bile acid and cholesterol deficiency in morbid obesity","volume":"281","author":"Straniero","year":"2017","journal-title":"J. Intern. Med."},{"key":"2023010508004414800_B154","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.035","article-title":"Regulation of bile acid synthesis by the nuclear receptor Rev-erb\u03b1","volume":"135","author":"Duez","year":"2008","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B155","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbalip.2014.04.008","article-title":"Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice","volume":"1851","author":"Qi","year":"2015","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"2023010508004414800_B156","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/labinvest.2010.107","article-title":"Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice","volume":"90","author":"Stroeve","year":"2010","journal-title":"Lab. Investig."},{"key":"2023010508004414800_B157","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncomms8231","article-title":"Circadian control of bile acid synthesis by a KLF15-Fgf15 axis","volume":"6","author":"Han","year":"2015","journal-title":"Nat. Commun."},{"key":"2023010508004414800_B158","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jcmgh.2015.08.003","article-title":"Short-term circadian disruption impairs bile acid and lipid homeostasis in mice","volume":"1","author":"Ferrell","year":"2015","journal-title":"Cmgh"},{"key":"2023010508004414800_B159","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbi.2021.07.006","article-title":"Ruminiclostridium 5, Parabacteroides distasonis, and bile acid profile are modulated by prebiotic diet and associate with facilitated sleep\/clock realignment after chronic disruption of rhythms","volume":"97","author":"Thompson","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"2023010508004414800_B160","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/cells10102656","article-title":"Oxysterol 7-\u03b1 hydroxylase (CYP7B1) attenuates metabolic-associated fatty liver disease in mice at thermoneutrality","volume":"10","author":"Evangelakos","year":"2021","journal-title":"Cells"},{"key":"2023010508004414800_B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2022.836741","article-title":"Cold-induced lipoprotein clearance in Cyp7b1-deficient mice","volume":"10","author":"Evangelakos","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"2023010508004414800_B162","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nm.4357","article-title":"Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis","volume":"23","author":"Worthmann","year":"2017","journal-title":"Nat. Med."},{"key":"2023010508004414800_B163","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.cmet.2016.05.001","article-title":"Altered microbiota contributes to reduced diet-induced obesity upon cold exposure","volume":"23","author":"Zi\u0119tak","year":"2016","journal-title":"Cell Metab."},{"key":"2023010508004414800_B164","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/mSphere.00140-18","article-title":"The Lactobacillus bile salt hydrolase repertoire reveals niche-specific adaptation","volume":"3","author":"O'Flaherty","year":"2018","journal-title":"MSphere"},{"key":"2023010508004414800_B165","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1249\/MSS.0b013e3181cfcb02","article-title":"Exercise enhances whole-body cholesterol turnover in mices","volume":"42","author":"Meissner","year":"2010","journal-title":"Med. Sci. Sports Exerc."},{"key":"2023010508004414800_B166","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.atherosclerosis.2011.06.040","article-title":"Voluntary wheel running increases bile acid as well as cholesterol excretion and decreases atherosclerosis in hypercholesterolemic mice","volume":"218","author":"Meissner","year":"2011","journal-title":"Atherosclerosis"},{"key":"2023010508004414800_B167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-015-0093-3","article-title":"Aerobic exercise training enhances the in vivo cholesterol trafficking from macrophages to the liver independently of changes in the expression of genes involved in lipid flux in macrophages and aorta","volume":"14","author":"Pinto","year":"2015","journal-title":"Lipids Health Dis"},{"key":"2023010508004414800_B168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.122737","article-title":"Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans","volume":"3","author":"Morville","year":"2018","journal-title":"JCI Insight"},{"key":"2023010508004414800_B169","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/oby.22627","article-title":"Ratio of conjugated chenodeoxycholic to muricholic acids is associated with severity of nonalcoholic steatohepatitis","volume":"27","author":"Chen","year":"2019","journal-title":"Obesity"},{"key":"2023010508004414800_B170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"2023010508004414800_B171","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2023010508004414800_B172","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","article-title":"Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease","volume":"268","author":"Lake","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2023010508004414800_B173","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab."},{"key":"2023010508004414800_B174","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J Hepatol"},{"key":"2023010508004414800_B175","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"2023010508004414800_B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS ONE"},{"key":"2023010508004414800_B177","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ygh2.374","article-title":"Circulating bile acid profiles in Japanese patients with NASH","volume":"1","author":"Yara","year":"2019","journal-title":"GastroHep"},{"key":"2023010508004414800_B178","doi-asserted-by":"publisher","first-page":"154457","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"key":"2023010508004414800_B179","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.jhepr.2020.100222","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2021","journal-title":"JHEP Rep."},{"key":"2023010508004414800_B180","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"2023010508004414800_B181","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"2023010508004414800_B182","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","article-title":"Bile acid levels are increased in the liver of patients with steatohepatitis","volume":"20","author":"Aranha","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2023010508004414800_B183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines10030524","article-title":"The role of gut-liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC","volume":"10","author":"Song","year":"2022","journal-title":"Biomedicines"},{"key":"2023010508004414800_B184","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","article-title":"Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease","volume":"157","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology"},{"key":"2023010508004414800_B185","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"2023010508004414800_B186","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"2023010508004414800_B187","doi-asserted-by":"publisher","first-page":"eabo2794","DOI":"10.1126\/sciadv.abo2794","article-title":"Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury","volume":"2794","author":"Li","year":"2022","journal-title":"Sci. Adv."},{"key":"2023010508004414800_B188","doi-asserted-by":"publisher","first-page":"791.e7","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab."},{"key":"2023010508004414800_B189","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/hepr.13444","article-title":"Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice","volume":"50","author":"Li","year":"2020","journal-title":"Hepatol. Res."},{"key":"2023010508004414800_B190","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jhep.2020.03.024","article-title":"Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study","volume":"73","author":"Newsome","year":"2020","journal-title":"J. Hepatol."},{"key":"2023010508004414800_B191","doi-asserted-by":"publisher","first-page":"G371","DOI":"10.1152\/ajpgi.00400.2012","article-title":"Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice","volume":"304","author":"Potthoff","year":"2013","journal-title":"Am. J. Physiol. - Gastrointest Liver Physiol."},{"key":"2023010508004414800_B192","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/srep00430","article-title":"TGR5 potentiates GLP-1 secretion in response to anionic exchange resins","volume":"2","author":"Harach","year":"2012","journal-title":"Sci. Rep."},{"key":"2023010508004414800_B193","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1872-034X.2009.00507.x","article-title":"Treatment of nonalcoholic steatohepatitis with colestimide","volume":"39","author":"Taniai","year":"2009","journal-title":"Hepatol. Res."},{"key":"2023010508004414800_B194","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"key":"2023010508004414800_B195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.127197","article-title":"NTCP deficiency in mice protects against obesity and hepatosteatosis","volume":"4","author":"Donkers","year":"2019","journal-title":"JCI Insight"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/137\/1\/65\/941586\/cs-2022-0697c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/137\/1\/65\/941586\/cs-2022-0697c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:01:38Z","timestamp":1672887698000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/137\/1\/65\/232393\/Biological-tuners-to-reshape-the-bile-acid-pool"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":195,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,13]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20220697","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1]]},"published":{"date-parts":[[2023,1]]}}}